Nicolas Aide

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 25

Top Venues

European journal of nuclear medicine and molecular imaging

EJNMMI research

Cancer imaging : the official publication of the International Cancer Imaging Society

Diagnostics (Basel, Switzerland)

CHU Clemenceau

Université Paris 14 (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHU Clemenceau Sep 01 2014

France

Full time professor (Nuclear Medicine) :: Nuclear Medicine department

Centre François Baclesse Centre de Lutte Contre le Cancer Nov 01 2004 - Sep 15 2014

France

Full time practitionner :: Nuclear Medicine Department

Peter MacCallum Cancer Institute Oct 01 2009 - Jun 29 2010

Australia

Research fellow :: Centre for molecular imaging

CHU Tenon Jan 11 2002 - Nov 01 2004

France

Chief resident :: PET centre

Education History

Université Paris 14

France

MSC

Université Paris-Sud (Doctoral School of Cancerology)

France

PHD

Publications

Laurent Dercle, Shawn H Sun, Romain-David Seban, Ahmed Mekki, Roger Sun, Lambros Tselikas, Sophie Hans, Alice Bernard-Tessier, Fadila Mihoubi Bouvier, Nicolas Aide, Laetitia Vercellino, Alexia Rivas, Antoine Girard, Fatima-Zohra Mokrane, Guillaume Manson, Roch Houot, Egesta Lopci, Randy Yeh, Samy Ammari, Lawrence H Schwartz
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging. Radiology (2022)
Nicolas Aide, Kathleen Weyts, Charline Lasnon
Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic 18 F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Nicolas Aide, Amir Iravani, Kevin Prigent, Diane Kottler, Ramin Alipour, Rodney J Hicks
PET/CT variants and pitfalls in malignant melanoma. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Jean-Baptiste Le Goubey, Charline Lasnon, Ines Nakouri, Laure Césaire, Michel de Pontville, Catherine Nganoa, Diane Kottler, Nicolas Aide
18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital. Diagnostics (Basel, Switzerland) 11 (7) (2021)
Kevin Prigent, Charline Lasnon, Emilien Ezine, Mélanie Janson, Nicolas Coudrais, Elisa Joly, Laure Césaire, Andrea Stefan, Michel Depontville, Nicolas Aide
Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients. European journal of nuclear medicine and molecular imaging 48 (8) (2021)
Pierre-André Zimmermann, Benjamin Houdu, Laure Césaire, Ines Nakouri, Michel De Pontville, Charline Lasnon, Nicolas Aide
Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET/CT with small-voxel reconstruction. Annals of nuclear medicine 35 (6) (2021)
Roberto C Delgado Bolton, Nicolas Aide, Patrick M Colletti, Annamaria Ferrero, Diana Paez, Andrea Skanjeti, Francesco Giammarile
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). European journal of nuclear medicine and molecular imaging 48 (10) (2021)
Nicolas Aide, Charline Lasnon, Adam Kesner, Craig S Levin, Irene Buvat, Andrei Iagaru, Ken Hermann, Ramsey D Badawi, Simon R Cherry, Kevin M Bradley, Daniel R McGowan
New PET technologies - embracing progress and pushing the limits. European journal of nuclear medicine and molecular imaging 48 (9) (2021)
Nicolas Aide, Laure-Eugénie Tainturier, Cathy Nganoa, Benjamin Houdu, Jennifer Kammerer, Marie-Pierre Galais, Renaud Ciappuccini, Charline Lasnon
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake. EJNMMI research 10 (1) (2020)
Nicolas Aide, Pauline Fauchille, Elodie Coquan, Gwenael Ferron, Pierre Combe, Jérome Meunier, Jerôme Alexandre, Dominique Berton, Alexandra Leary, Gaétan De Rauglaudre, Nathalie Bonichon, Eric Pujade Lauraine, Florence Joly
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer. European journal of nuclear medicine and molecular imaging 48 (6) (2020)
David Dudoignon, David A Pattison, Damien Legallois, Rodney J Hicks, Nicolas Aide
The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT. Cancer imaging : the official publication of the International Cancer Imaging Society 20 (1) (2020)
Magno Oliveira, Charline Lasnon, Catherine Nganoa, Anne-Claire Gac, Gandhi Damaj, Nicolas Aide
Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling. EJNMMI research 9 (1) (2019)
Arthur Letellier, Alison C Johnson, Nicolas How Kit, Jean-François Savigny, Alain Batalla, Jean-Jacques Parienti, Nicolas Aide
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients. Molecular imaging and biology 20 (3) (2019)
Nicolas Aide, Thibault Salomon, Charline Lasnon
Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis. European journal of nuclear medicine and molecular imaging 45 (12) (2018)
Nicolas Aide, Charline Lasnon, Gandhi Damaj
Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma. European journal of nuclear medicine and molecular imaging 45 (5) (2018)
Benjamin Houdu, Charline Lasnon, Idlir Licaj, Guy Thomas, Pascal Do, Anne-Valerie Guizard, Cédric Desmonts, Nicolas Aide
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer. European journal of nuclear medicine and molecular imaging 46 (2) (2018)
Charline Lasnon, Blandine Enilorac, Nicolas Aide
Reply to: "All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting". European journal of nuclear medicine and molecular imaging 45 (5) (2018)
Nicolas Aide, Rodney J Hicks, Christophe Le Tourneau, Stéphanie Lheureux, Stefano Fanti, Egesta Lopci
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature. European journal of nuclear medicine and molecular imaging 46 (1) (2018)
Charline Lasnon, Blandine Enilorac, Hosni Popotte, Nicolas Aide
Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs). EJNMMI research 7 (1) (2017)
Charline Lasnon, Elske Quak, Pierre-Yves Le Roux, Philippe Robin, Michael S Hofman, David Bourhis, Jason Callahan, David S Binns, Cédric Desmonts, Pierre-Yves Salaun, Rodney J Hicks, Nicolas Aide
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program. EJNMMI physics 4 (1) (2017)
Nicolas Aide, Charline Lasnon, Patrick Veit-Haibach, Terez Sera, Bernhard Sattler, Ronald Boellaard
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. European journal of nuclear medicine and molecular imaging 44 (Suppl 1) (2017)
Thibault Salomon, Catherine Nganoa, Anne-Claire Gac, Christophe Fruchart, Gandhi Damaj, Nicolas Aide, Charline Lasnon
Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. European journal of nuclear medicine and molecular imaging 45 (6) (2017)
Nicolas Aide, Stefano Fanti
Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community. European journal of nuclear medicine and molecular imaging 44 (Suppl 1) (2017)
Alison C Johnson, Audrey Emmanuelle Dugué, Marlon Silva, Laura Moise, Xavier Tillou, Florence Joly, Nicolas Aide
Predictive factors of 18F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated? EJNMMI research 6 (1) (2016)
Charline Lasnon, Mohamed Majdoub, Brice Lavigne, Pascal Do, Jeannick Madelaine, Dimitris Visvikis, Mathieu Hatt, Nicolas Aide
18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer. European journal of nuclear medicine and molecular imaging 43 (13) (2016)

Nicolas Aide.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Aide